Nano Labs
4 hedge funds and large institutions have $6.78K invested in Nano Labs in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
2% more capital invested
Capital invested by funds: $6.62K → $6.78K (+$162)
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$546 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$2.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
RhumbLine Advisers
Boston,
Massachusetts
| $4.26K | – | – | – |
|
|
2
Barclays
London,
United Kingdom
| $1.38K | -$2.79K | -184 | -71% |
|
|
3
UBS Group
Zurich,
Switzerland
| $934 | +$546 | +36 | +225% |
|
4
Qube Research & Technologies (QRT)
London,
United Kingdom
| $209 | – | – | – |
|
NA Hedge Fund Activity: Q4 2023 in Review
4 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Nano Labs (NA) for Q4 2023, worth a combined $6.78K — up 2.4% from $6.62K a quarter earlier.
Fund positioning in NA was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $546. The largest seller was Barclays, cutting an estimated $2.79K.
- 4 institutional investors held Nano Labs (NA) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $6.78K of Nano Labs stock for Q4 2023, up 2.4% quarter-over-quarter.
- 0 funds opened new Nano Labs positions in Q4 2023 and 0 closed out.
- The largest Nano Labs buyer in Q4 2023 was UBS Group, an estimated $546 added.
- The largest Nano Labs seller in Q4 2023 was Barclays, an estimated $2.79K sold.
Based on aggregated 13F filings for Q4 2023.